Recent China medical-device activity, turned into evidence-backed sales leads.
For U.S. Agents, EU/UK representatives, and MedTech regulatory consultancies. Test the evidence with a 10-company Starter or the full current release matched to your service.
One pack, one quarter of outreach
- Chinese-domiciled registrants with recent NMPA activity
- Public business contact channels and official websites
- Cross-market registry matching with confidence grades
- 12 companies with confirmed FDA establishment registrations
- Delivery within 48 hours after verified full payment
Who this is for
Firms whose revenue depends on finding the next foreign medical-device manufacturer that needs representation or compliance help:
FDA U.S. Agent providers
Chinese manufacturers filing new NMPA device records are your fastest-growing prospect pool. Each record shows the registrant, product category, and when the activity happened.
EU/UK authorised representatives and consultancies
EUDAMED Actor registration became mandatory in May 2026. Manufacturers with fresh domestic activity and export-ready signals are timely outreach targets for EU AR, UKRP, ISO 13485, and CE services.
What each record includes
| Field group | What you get |
|---|---|
| Identity | Company name (Chinese and English when published), unified social credit code, province decoded from the GB 32100-2015 code. |
| Contact | Published business email and official website from public sources, with retrieval dates. |
| Activity | NMPA activity date, count of new device records, representative products, registration references, and product category. |
| Evidence | Cross-market registry matching (e.g., FDA registration-listing data), confidence grade A or B, source links, and a cautious "why now" note. |
| Guidance | A suggested outreach angle per company — no outreach performed on your behalf. |
Evidence and confidence method
Source NMPA UDI daily releases (udid.nmpa.gov.cn), checksum-verified before parsing.
Honest limits Recent NMPA activity is a commercial timing signal, not compliance proof. openFDA matching is deliberately conservative: ambiguous or failed queries become "review" or "unknown", never a silent assumption.
Every paid lead passes evidence gates: an official regulatory source, an independent corporate source, a published business contact, working source links, a retrieval date, confidence grade A or B, a grounded "why now" statement, and an independent second-pass validation.
Scoring model
1.0.0, weighted across recency, volume and commercial relevance, export readiness, target-market opportunity, and contactability. The evidence threshold is never silently lowered.
A product is offered only when enough companies pass every evidence gate. We never lower quality to fill a pack.
Offers
10-company Starter
- 10 evidence-passed companies
- XLSX lead pack and executive PDF brief
- Public contacts, sources, confidence grades, and outreach angles
- Delivery within 48 hours after verified full payment
A low-risk paid test using the same evidence standard as the full release.
Full current release
- Every evidence-passed company in the current release (17 this week)
- XLSX lead pack and executive PDF brief
- Public contacts, sources, confidence grades, and outreach angles
- Delivery within 48 hours after verified full payment
The complete current release for your segment - more records to test fit across products and provinces.
Before you order
Download the public sample to inspect the format and source fields. If it fits your sales motion, use the PayPal button on the pack you want, or email us and we will confirm scope and delivery.
Payment is collected through a verified PayPal account; the selected pack is delivered within 48 hours after the payment clears.
If a published contact or evidence link is invalid, report it within seven days and we will replace that lead at no cost. This is not a guarantee of replies, revenue, or regulatory outcomes.
FAQ
Who is this for?
FDA U.S. Agent providers, EU/UK authorised representatives, and medical-device regulatory consultancies that sell representation, registration, certification, or market-entry services to foreign manufacturers.
What does one record include?
Company identity (Chinese and English when published), province, unified social credit code, official website, published business email, NMPA activity date, new device records, representative products, registration references, product category, cross-market match evidence, confidence grade, "why now", suggested outreach angle, source links, and retrieval date.
Is this legal or regulatory advice?
No. This is a sales-intelligence product built from public sources. It is not a legal opinion, regulatory verification, compliance determination, or official database, and it makes no claim about any company's FDA or EUDAMED registration status.
Are the leads exclusive?
No. Each pack is licensed non-exclusively for internal use by one purchasing company. Resale and republication are prohibited. We may sell packs covering the same companies to other buyers.
What happens if a record has an invalid contact or source?
Report an invalid published contact or broken evidence link within seven days and we will replace that lead at no cost. We never lower the evidence threshold.
How is payment handled?
Through a verified PayPal account (paypal.me/lexianginfo) after a written order confirmation. The pack is delivered within 48 hours after verified full payment. No card data is collected on this site.
Inspect the 3-company proof sample
Download it immediately—no email address or personal information is required. It shows one complete sales-ready lead and two contact-redacted records using the same structure as the paid pack.
We count the download event without storing your IP address. The file still downloads if that notification is temporarily unavailable.